Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 202

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Review article: spontaneous bacterial peritonitis – bacteriology, diagnosis, treatment, risk factors and prevention

Dever, J. B., Sheikh, M. Y. · 2015 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Spontaneous bacterial peritonitis (SBP) is a severe and often fatal infection in patients with cirrhosis and ascites. Aim: To review the known and changing bacteriology, risk factors, ascitic fluid interpretation, steps in performing paracentesis, treatment, prophylaxis and evolving perspectives related to SBP. Methods: Information was obtained from reviewing medical literature accessible on PubMed Central. The search term ‘spontaneous bacterial peritonitis’ was cross‐referenced with ‘bacteria’, ‘risk factors’, ‘ascites’, ‘paracentesis’, ‘ascitic fluid analysis’, ‘diagnosis’, ‘treatment’, ‘antibiotics’, ‘prophylaxis’, ‘liver transplantation’ and ‘nutrition’. Results: Gram‐positive cocci (GPC) such as Staphylococcus, Enterococcus as well as multi‐resistant bacteria have become common pathogens and have changed the conventional approach to treatment of SBP. Health care‐associated and nosocomial SBP infections should prompt greater vigilance and consideration for alternative antibiotic coverage. Acid suppressive and beta‐adrenergic antagonist therapies are strongly associated with SBP in at‐risk individuals. Conclusions: Third‐generation, broad‐spectrum cephalosporins remain a good initial choice for SBP treatment. Levofloxacin is an acceptable alternative for patients not receiving long‐term flouroquinolone prophylaxis or for those with a penicillin allergy. For uncomplicated SBP, early oral switch therapy is reasonable. Alternative antibiotics such as pipercillin–tazobactam should be considered for patients with nosocomial SBP or for patients who fail to improve on traditional antibiotic regimens. Selective albumin supplementation remains an important adjunct in SBP treatment. Withholding acid suppressive medication deserves strong consideration, and discontinuing beta‐adrenergic antagonist therapy in patients with end‐stage liver disease and resistant ascites is standard care. Liver transplant evaluation should be undertaken for patients who develop SBP barring contraindications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13172

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 202

Metadata

Authors
Dever, J. B., & Sheikh, M. Y.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2015-03-26
Volume
41
Issue
11
Pages
1116-1131
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2065590798
Cited by
202
References
8
FWCI
10.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.